Health Inventures Names Dr. Charles Peck as New President and CEO

Health Inventures, a developer and operator of ASCs and surgical hospitals, has named Charles Peck, MD, as its new president and CEO, effective Jan. 3, 2011.

Advertisement

 

Dr. Peck has over 30 years of diverse healthcare experience. He is an internist and rheumatologist by training and served as a clinician, scientist, faculty member, executive, and partner in worldwide healthcare consulting firms, according to a news release from Health Inventures.

 

Prior to joining Health Inventures, he served as the chief medical officer and managing director of FTI Healthcare, a healthcare consulting firm which specializes in change management, financial advisory and consulting services. At FTI, Dr. Peck’s particular areas of focus were clinical integration, physician enterprise development, physician and hospital alignment, clinical operations and care management.

 

“The rapidly changing healthcare marketplace creates significant opportunities for companies with the wherewithal and reputation of Health Inventures,” said Dr. Peck in the news release. “Ambulatory service development and operations, along with physician-hospital alignment, are core competencies that will be in heavy demand among providers attempting to be competitive in the new delivery landscape. I look forward to the challenge of working with [Health Inventure’s] leadership to build upon their significant accomplishments to date.”

 

Dr. Peck will assume the role currently held by CEO Richard Hanley, who earlier this year announced his plans to retire at the end of the year. Mr. Hanley first joined the ASC industry almost 30 years ago. He was a founder of Health Inventures, which now has 30 surgical facilities in 11 states. Mr. Hanley has served in a variety of industry leadership positions, including his current role on the boards of the Ambulatory Surgery Foundation and Ambulatory Surgery Center Association.

 

Learn more about Health Inventures.

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.